Background: Auricular keloids are challenging to manage, and recurrent keloids are more aggressive and likely to cause auricular deformities. Monotherapy such as surgical resection, injection, or radiotherapy alone has a high recurrence rate. The treatment approach for auricular keloids remains to be investigated.

Methods: A retrospective analysis was conducted on 30 patients who received treatment at the Department of Plastic and Reconstructive Surgery, Shanghai Ninth People's Hospital, between December 2021 and May 2023. Based on the size, location, and extent of keloid invasion, the appearance of auricle was reconstructed by repairing scar flap after excision of the keloid and its core or resection. Postoperative injections of triamcinolone were administered within one week after suture removal, followed by every two weeks for 4-6 times.

Results: 30 patients were followed up for 6-36 months after the operation. The POSAS score of the patients was significantly lower than that before the operation. Among them, one patient relapsed due to failure to receive regular postoperative injections, one patient experienced delayed healing due to local hair interference, and two patients had menstrual disorders during the injection.

Conclusion: For keloids with diverse morphologies and anatomic locations, adopting individualized combined treatment involving surgical excision and intralesional triamcinolone acetonide injections can achieve the reconstruction of auricle morphology and maintain a long-term therapeutic effect.

Level of evidence iv: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .

Keywords: Auricular keloid; Corticosteroids; Keloid surgery; Recurrence; Retrospective study; Treatment outcome.

© 2025. Springer Science+Business Media, LLC, part of Springer Nature and International Society of Aesthetic Plastic Surgery.

背景： 耳部瘢痕疙瘩难以管理，复发性瘢痕疙瘩更具侵略性，并可能导致耳廓畸形。单独使用手术切除、注射或放射治疗的单药疗法复发率较高。对于耳部瘢痕疙瘩的治疗方法仍需进一步研究。

方法： 回顾分析了2021年12月至2023年5月期间在上海第九人民医院整形与重建外科接受治疗的30名患者的资料。根据瘢痕疙瘩的大小、位置和侵袭范围，通过切除瘢痕及其核心或进行切片修复来重塑耳廓外观。术后在拆线后一周内开始皮质类固醇注射（曲安奈德），随后每两周一次，共4-6次。

结果： 30名患者术后随访时间为6至36个月。患者的POSAS评分明显低于术前水平。其中一名患者因未按时接受术后注射而复发，一名患者由于局部毛发干扰导致愈合延迟，两名患者在注射期间出现月经紊乱。

结论： 对于形态和解剖位置多样的瘢痕疙瘩，采用个性化综合治疗方案（包括手术切除和病灶内曲安奈德注射）可以实现耳廓形态重塑，并保持长期疗效。

证据等级IV: 本期刊要求作者为每篇文章分配一个证据级别。有关这些循证医学评级的详细描述，请参阅目录或在线作者指南www.springer.com/00266 。

关键词： 耳部瘢痕疙瘩；皮质类固醇；瘢痕手术；复发性；回顾性研究；治疗效果。